Any stock, in context
HESTERBIO · Healthcare
Hester Biosciences Limited
Observation · 15 Oct 2026
How these are readHester Biosciences closed at ₹2,196.4 on 15 Oct 2026, 16.9% above its 200-day average and 3.7% below its 50-day average: above the long line, below the short one. It sits 13.3% below its highest close of the past year, in the fourth fifth of its one-year range. Over three months it fell 10.3%, against a median of −2.7% for its sector (146 stocks) and −5.1% for every stock observed.
- vs 200-day
- +16.9%
- the long line
- vs 50-day
- −3.7%
- the short line
- From 52w high
- −13.3%
- ₹1,239.3₹2,683.6
- 3 months
- −10.3%
- sector median −2.7% · 104 of 146
Listed outside the Nifty indices · Healthcare (sector mapped from its industry) · EQ series · median traded value ₹1.01 crore a day. A description of where the price sits, not a view on the stock.
- 1D
- +1.79%
- 1W
- –
- 1M
- +1.13%
- 3M
- −10.27%
- YTD
- –
- 1Y
- +28.17%
Quotes come from Yahoo Finance through this site's server and are cached for fifteen minutes; when the provider fails, the stored close is shown and labelled. The observation is computed from the latest snapshot. For research and education only; not investment advice.